Galderma’s breakthrough drug Nemluvio gains rapid FDA approval for severe itch condition

Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for the treatment of prurigo nodularis in adults. ... Read More